Skip to Main Content
Contribute Try STAT+ Today

In a surprise move, Mark Cuban last week announced plans to enter the generic drug business with a new company bearing his name. The famed investor – known widely for his appearances on Shark Tank – has actually been eyeing the pharmaceutical world for a while. Two years ago, Cuban decided to work with Alex Oshmyansky to sell low-cost medicines. A radiologist by training, Oshmyansky had already started a company with a similar goal but reached out to Cuban to jumpstart the idea. “He is super smart. Knows the technology, knows the industry and works his ass off,” Cuban wrote us in explaining why he got involved. We spoke with Oshmyansky about his plans for getting the Mark Cuban Cost Plus Drug Company off the ground. This is an edited version of our conversation. 

Let’s talk about you and your background. You’re a physician, but before you got involved with Mark Cuban, you had started a company called OSH Pharmaceuticals. Why?

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.